- Home
- KRNY vs OLMA Comparison
KRNY vs OLMA Comparison
Compare KRNY & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- OLMA
- Stock Information
- Founded
- KRNY 1884
- OLMA 2006
- Country
- KRNY United States
- OLMA United States
- Employees
- KRNY N/A
- OLMA N/A
- Industry
- KRNY Savings Institutions
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- OLMA Health Care
- Exchange
- KRNY Nasdaq
- OLMA Nasdaq
- Market Cap
- KRNY 420.7M
- OLMA 378.9M
- IPO Year
- KRNY 2005
- OLMA 2020
- Fundamental
- Price
- KRNY $6.61
- OLMA $8.31
- Analyst Decision
- KRNY Buy
- OLMA Strong Buy
- Analyst Count
- KRNY 2
- OLMA 5
- Target Price
- KRNY $7.75
- OLMA $24.00
- AVG Volume (30 Days)
- KRNY 408.9K
- OLMA 848.0K
- Earning Date
- KRNY 10-23-2025
- OLMA 08-11-2025
- Dividend Yield
- KRNY 6.66%
- OLMA N/A
- EPS Growth
- KRNY N/A
- OLMA N/A
- EPS
- KRNY 0.42
- OLMA N/A
- Revenue
- KRNY $151,629,000.00
- OLMA N/A
- Revenue This Year
- KRNY $14.22
- OLMA N/A
- Revenue Next Year
- KRNY N/A
- OLMA N/A
- P/E Ratio
- KRNY $15.85
- OLMA N/A
- Revenue Growth
- KRNY 12.84
- OLMA N/A
- 52 Week Low
- KRNY $5.45
- OLMA $2.86
- 52 Week High
- KRNY $8.59
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- KRNY 60.69
- OLMA 80.61
- Support Level
- KRNY $6.54
- OLMA $5.99
- Resistance Level
- KRNY $6.88
- OLMA $6.85
- Average True Range (ATR)
- KRNY 0.16
- OLMA 0.51
- MACD
- KRNY 0.05
- OLMA 0.19
- Stochastic Oscillator
- KRNY 70.00
- OLMA 95.81
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.